Comparison of relationship between eosinophil counts and the disease severity in ACO patients

A. Ebihara (Tokyo, Japan), A. Nagai (Tokyo, Japan), T. Iwamoto (tokyo, Japan), I. Kuwahira (Tokyo, Japan)

Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Session: From tobacco-related comorbidities to tobacco cessation
Session type: Thematic Poster
Number: 4485
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ebihara (Tokyo, Japan), A. Nagai (Tokyo, Japan), T. Iwamoto (tokyo, Japan), I. Kuwahira (Tokyo, Japan). Comparison of relationship between eosinophil counts and the disease severity in ACO patients. 4485

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Relationship between blood eosinophil levels and severity of COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Correlation of neutrophil CD64 expression with disease severity in sepsis
Source: Annual Congress 2004 - Mechanisms and diagnosis of pulmonary infection diseases in the ICU
Year: 2004


Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



Association between blood eosinophil counts and risk of rehospitalization in patients with asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017



Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009


An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001

Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015


Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002

How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003